[Is PstI polymorphism of the angiotensin I converting enzyme gene associated with nephropathy development in non-insulin-dependent diabetes mellitus (preliminary study)].
Nephropathy is a frequent complication of long term diabetes. Diabetic nephropathy is the major determinant of premature morbidity and mortality both in insulin-dependent (IDDM) and in non-insulin dependent-diabetes mellitus (NIDDM). There is good evidence that genetic predisposition plays a major role in development of diabetic nephropathy. This hypothesis is based on the observation that diabetic nephropathy clusters within families, both in IDDM and NIDDM. Components of the renin-angiotensin system (RAS) are plausible candidate genes to examine for a association with microalbuminuria and diabetic nephropathy. In this study we compared the distribution of PstI melting polymorphism at the ACE locus among NIDDM patients with diabetic nephropathy and in patients who, despite long duration of NIDDM, remain without this complication. The 220 NIDDM patients for whom DNA was available were classified into two groups according to their renal status: normoalbuminuric control subjects (n = 80) who are NIDDM patients with an A/C ratio < 2.5 and nephropathy cases (n = 140) who are NIDDM patients with A/C ratio > 2.5. Albumin excretion rate was assayed by radioimmunoassay. HbA1c was assayed using HPLC methods, creatinine--using Jaffe methods and DNA analysis using PCR reaction, and then after the amplification product was digested with PstI enzyme. The study revealed that PstI sequence differences ("+/= and -") in the ACE gene do not contribute to genetic susceptibility to diabetic nephropathy in NIDDM.
Grzeszczak
W
W
Klinika Chorób Wewnetrznych i Diabetologii Slaskiej Akademii Medycznej.
Zychma
M
M
Zukowska-Szczechowska
E
E
Lacka
B
B
D000328:Adult; D000368:Aged; D001483:Base Sequence; D002851:Chromatography, High Pressure Liquid; D003404:Creatinine / Q000097:blood; D004247:DNA / Q000032:analysis; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics*; D003928:Diabetic Nephropathies / Q000235:genetics*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D008875:Middle Aged; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D012799:Sialyltransferases / Q000235:genetics*
D003404:Creatinine; D004247:DNA; D006442:Glycated Hemoglobin; D007703:Peptidyl-Dipeptidase A; D012799:Sialyltransferases; C046778:CMP-N-acetylneuraminate-poly-alpha-2,8-sialosyl sialyltransferase
Czy polimorfizm PstI genu enzymu konwertujacego łaczy sie ze zwiekszonym ryzykiem zapadalności na nefropatie u chorych na cukrzyce insulino-niezalezna (doniesienie wstepne).